HR 2855
116th Congress
House
To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2019
Referred to the Subcommittee on Health.
May 20, 2019
Referred to the House Committee on Energy and Commerce.
May 20, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Referred to the Subcommittee on Health.
Cite this page
U.S. Congress. (2026). H.R. 2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2855/
"H.R. 2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2855/.
H.R. 2855, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2855/.
[H.R. 2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.](https://openamerica.io/bill/116-HR-2855/)